The TGM™ opportunity
Non-invasive can be a transformative technology for tens or hundreds of millions. Needles and the fear of having to draw blood from oneself can be a major hurdle faced by people who want to understand their glucose levels.1 RSP Systems has developed a patented, clinically tested, non-invasive and non-intrusive glucose monitoring technology system that has the potential to be a game changer.
Note: The GlucoBeam™ touch glucose monitoring technology system is an investigations system not yet FDA cleared for commercial sale or use. Any subsequent variants of the technology or alterations to the base technology could require additional clearance or approval (510K, De Novo or PMA), depending on alterations to the base technology and desired claims or intended use.
1. Anxiety associated with self monitoring of capillary blood glucose, Br J Diabetes Vasc Dis 2014;14:60-63